The Air Liquide Foundation Supports 10 Scientific Projects & 21 Social Emergency Aid Projects in the Context of Its Covid-19 ...
September 08 2020 - 2:45AM
Business Wire
Regulatory News:
In response to the Health crisis, the Air Liquide (Paris:AI)
Foundation launched as early as March 2020 the Covid-19 Initiative.
More than 2 millions euros have been mobilized over two years, with
a double objective: to support scientific research projects and to
reinforce the help given to associations working with the most
vulnerable people to the Covid-19. In an emergency context, the
Foundation has already approved 10 scientific projects and 21
social emergency aid projects on all continents since March
2020.
Scientific projects to accelerate research on
Covid-19
Through the Covid-19 Initiative, the Air Liquide Foundation has
decided to support research projects aimed at better
understanding the virus and its transmission modes, improving its
treatment and determining its long term effects on lungs. 10
scientific projects responding to these key challenges have been
selected after assessment by doctors and Air Liquide experts as
well as after validation by a Scientific Committee. The Air Liquide
Foundation, in line with its mission to support research projects
on respiratory diseases, thus continues its commitment alongside
European research teams, so as to advance Science progress and
develop new health protocols.
Projects to support the populations most vulnerable to
Covid-19
The Air Liquide Foundation has also approved support to 21
social emergency projects, undertaken by partner associations of
the Foundation, on all continents. By providing food support or
protection equipment, by reconnecting people and raising awareness
of the coronavirus and barrier gestures, these projects help
isolated individuals particularly exposed to the Covid-19 virus and
to its social and economical consequences.
Since the month of March, 10 research projects and 21 social
emergency projects have been supported by the Foundation, in the
context of the Covid-19 Initiative, for a total amount of 1,1
million euros. All in all, more than 2 millions euros of
exceptional funding will be allocated over two years to the fight
against Covid-19.
Jean-Marc de Royere, Senior Vice President, Chairman of
the Air Liquide Foundation and member of the Group’s Executive
Committee: “We have two responsibilities in the face of the
health crisis: in the long term, we need to better understand the
Covid-19 virus to learn how to protect ourselves from it, and in
the short term, we must support those who are most vulnerable to
it. In an unprecedented context, the Air Liquide Foundation has
very rapidly launched the Covid-19 Initiative to commit to these
two major issues, with the support of the Group’s expertise. I
commend the commitment of Air Liquide’s collaborators, through the
Foundation as on the field.”
The Air Liquide Foundation
The corporate Air Liquide Foundation responds to societal
challenges by working with scientific institutions and civil
society organizations. It draws on the Group's expertise and
operates in territories where Air Liquide is present throughout the
world. The Air Liquide Foundation actions are twofold : on the one
hand, it promotes scientific research and education on respiratory
diseases and air quality, and on the other hand, it supports the
local development of territories in particular for the professional
integration of young people. Since its creation in 2008, it has
supported more than 365 projects in more than 52 countries, with a
specificity, which consists in relying on Air Liquide scientific or
operational teams, who follow each project and guarantee the
quality of the Foundation interventions.
To know more about the projects launched in the context of the
Covid-19 Initiative:
https://www.fondationairliquide.com/en/foundation/covid-19-air-liquide-foundation-work
--------------------------
A world leader in gases, technologies and services for Industry
and Health, Air Liquide is present in 80 countries with
approximately 67,000 employees and serves more than 3.7 million
customers and patients. Oxygen, nitrogen and hydrogen are essential
small molecules for life, matter and energy. They embody Air
Liquide’s scientific territory and have been at the core of the
company’s activities since its creation in 1902.
Air Liquide’s ambition is to be a leader in its industry,
deliver long term performance and contribute to sustainability. The
company’s customer-centric transformation strategy aims at
profitable, regular and responsible growth over the long term. It
relies on operational excellence, selective investments, open
innovation and a network organization implemented by the Group
worldwide. Through the commitment and inventiveness of its people,
Air Liquide leverages energy and environment transition, changes in
healthcare and digitization, and delivers greater value to all its
stakeholders.
Air Liquide’s revenue amounted to 22 billion euros in 2019 and
its solutions that protect life and the environment represented
more than 40% of sales. Air Liquide is listed on the Euronext Paris
stock exchange (compartment A) and belongs to the CAC 40, EURO
STOXX 50 and FTSE4Good indexes.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200907005349/en/
Corporate Communications media@airliquide.com
Investor Relations IRTeam@airliquide.com
Air Liquide (EU:AI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Air Liquide (EU:AI)
Historical Stock Chart
From Sep 2023 to Sep 2024